ENTPD1 and neoplasm: Based on the results of other research groups, tumor escape mechanisms apparently benefit from the presence of immunosuppressive ADO; the dysfunction of the ectonucleotidases CD39 and CD73 is associated with reduced tumor growth [38–40], and up-regulation of CD73 on tumor cells is linked to increased risk for metastasis and increased chemo resistance [41–43].